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Abstract
Objective—To assess the effect of delayed cord clamping (DCC) versus immediate cord 
clamping (ICC) on intraventricular hemorrhage (IVH), late onset sepsis (LOS), and 18-month 
motor outcomes in preterm infants.
Study design—Women (n=208) in labor with singleton fetuses (≤ 32 weeks gestation) were 
randomized to either DCC (30–45 seconds) or ICC (< 10 seconds). The primary outcomes were 
IVH, LOS, and motor outcomes at 18–22 months corrected age. Intention-to-treat was used for 
primary analyses.
Results—Cord clamping time was 32 ± 16 seconds (DCC) vs. 6.6 ± 6 (ICC). Infants in the DCC 
and ICC groups weighed 1203 ± 352 grams and 1136 ± 350 and mean gestational age was 28.3 ± 
2 and 28.4 ± 2 weeks respectively. There were no differences in rates of IVH or LOS between 
groups. At 18–22 months, DCC was protective against motor scores below 85 on the Bayley 
Scales of Infant Development-III (Bayley-III) (OR 0.32, 95% CI 0.10 – .0.90, p = 0.03). There 
were more women with preeclampsia (PEC) in the ICC group (37% vs 22%, p = 0.02) and more 
women in the DCC group with premature rupture of membranes/ preterm labor (PROM/PTL) 
(54% vs 75%, p = 0.002). PEC halved the risk of IVH (OR 0.50, 95% CI 0.2 – 1.0) and 
PROM/PTL doubled the risk of IVH (OR 2.0, 95% CI 1.2–4.3).
Conclusions—Although DCC did not alter the incidence of IVH or LOS in preterm infants, it 
improved motor function at 18–22 months corrected age.
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When cord clamping is delayed at birth or the cord is milked, infants receive a placental 
transfusion of 10 to 15 mL/kg during the first few minutes of life.1 This additional blood 
improves hemodynamic stability and may reduce the risk of intraventricular hemorrhage 
(IVH)2, 3 and the vulnerability of infants to inflammatory processes.4–6 This blood also 
contains stem cells that are important in repairing tissue and building immunocompetence.7 
Recently, the American College of Obstetricians and Gynecologists recommended delayed 
cord clamping (DCC) for preterm infants when feasible but the current obstetrical practice at 
birth remains immediate clamping.8–10
Prior studies on DCC in preterm infants have shown benefits without harm. The most recent 
meta-analysis by Rabe et al on infants under 37 weeks found reduced rates of neonatal 
transfusion (OR 0.61, 95% CI 0.46 – 0.81, p < 0.0005), less IVH (OR 0.59, 95% CI 0.41 – 
0.85, p < 0.005) and no difference in late onset sepsis (LOS).11 Backes et al reported similar 
findings in infants less than 32 weeks adding a finding of lower mortality (OR 0.42, 95% CI 
0.19–0.95, p =0.04).12 Previously, we reported reduced rates of IVH and LOS13 and some 
protection of very low birth weight (VLBW) male infants against motor disability at 7 
months corrected age.14
The current randomized controlled trial prospectively tested the effects of DCC for 30 to 45 
seconds followed by one cord milking with the aim of confirming our prior work and 
providing long term follow-up. Our a priori hypotheses were that DCC would reduce the 
incidence of IVH, LOS, and result in better motor function at 18–22 months.
Methods
This trial was conducted at Women and Infants’ Hospital (WIH) of Rhode Island with WIH 
and the University of Rhode Island Institutional Review Board approval. Thirty patients 
(14%) were enrolled prior to trial registration, but no data were examined prior to trial 
registration. An independent data safety and monitoring committee reviewed the data after 
36, 100, and 150 infants were randomly assigned and identified no concerns. Women with a 
singleton pregnancy estimated at 24 to 31.6 weeks gestation by obstetrical evaluation were 
eligible irrespective of mode of delivery. Exclusion criteria included multiple gestation, 
prenatally diagnosed major congenital anomalies, severe or multiple maternal illnesses, and 
mothers who were at risk for loss to follow-up. Blocked stratified randomization of subjects 
born before or after 28 weeks to the immediate cord clamping (ICC) or DCC group was 
used to assign the groups with a prespecified equal probability. Sequenced and sealed 
envelopes identifying the stratification and group assignment on cards were prepared by a 
statistician not involved in the trial and kept in a locked file box in the Labor and Delivery 
Unit. All participants were screened, consented and enrolled by study nurses following 
written informed consent. Study nurses randomized mothers based on the next study card 
designation when women went into active labor.
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Women were randomized to either DCC followed by one milking of the cord (intervention 
group) or ICC (control group). For all births, research personnel used a stopwatch to record 
the exact timing of cord clamping. Once the cord was cut, the infant was moved to the 
warmer and placed on a warming mattress. All subsequent care was managed by the 
neonatal team in attendance. For the DCC group, the obstetrician placed the infant in a 
sterile warm towel or blanket and held the infant approximately 10–15 inches below the 
mother’s introitus at vaginal delivery or below the level of the placenta at cesarean delivery. 
Care was taken to avoid traction on the cord. Suctioning was at the discretion of the 
obstetrician. The research nurse, using a stopwatch, counted out the time elapsed in ten 
second intervals to the obstetrician. At 30 to 45 seconds, the obstetrician was asked to milk 
the infant’s cord once then clamp and cut the umbilical cord. If unable to carry out the DCC 
protocol as planned, the cord was milked quickly 2 to 3 times before clamping when 
possible (n = 11). In the event that the timing of the cord clamping was less than 30 seconds 
with no cord milking and the baby was randomized to the DCC group, a protocol violation 
report was completed and the infant remained in the DCC group for primary intention-to-
treat analyses (n = 15). The ICC group received routine care of cord clamping in less than 10 
seconds. Cranial ultrasounds were obtained at one, seven, and 28 days. Formal 
developmental follow-up assessments at seven and 18 – 22 months corrected age were 
completed.
IVH was defined as bleeding in the brain assessed by cranial ultrasound readings using the 
criteria of Papile.15 The staff pediatric radiologist read the ultrasound initially followed by a 
collaborating pediatric radiologist masked to the infants’ grouping. Discrepancies were 
adjudicated by consensus through discussion among radiologists. LOS was defined as a 
positive bacterial blood culture after 72 hours of age. The Bayley Scales of Infant 
Development Motor Scale (Bayley-III) was used to assess cognitive, language and motor 
function.16 The motor composite score and subscores for fine motor and gross motor skills 
were analyzed. The Bayley-III composite score has a mean ± SD of 100 ±15.
Secondary outcome variables included safety variables (Apgar scores, initial temperature 
upon admission, peak bilirubin in the first week of life), initial blood pressure, initial 
hematocrit, necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), and 
retinopathy of prematurity (ROP) as diagnosed by attending clinicians. NEC was diagnosed 
based on Bell criteria, BPD was defined as requiring oxygen therapy at 36 weeks 
postmenstrual age or death, and ROP was identified by an ophthalmologist per routine eye 
examinations.
The study could not be blinded because of the obvious nature of the intervention. Our 
institutional policy requires the presence of a neonatology staff member at delivery because 
of early gestation. Staff who attended each birth were asked not to reveal the infant’s 
grouping in the infant’s medical records. Personnel collecting on-going clinical data and the 
follow-up staff completing the developmental assessment remained blinded.
The power analysis was based on our Phase 1 study13 and expected treatment effects for a 
simple test of proportions of group differences (ICC vs. DCC) for the primary study 
outcome of IVH. We conservatively estimated an odds ratio of about 2.5 for this new study, 
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which yielded a sample size of 92 per group for power of 0.80. Given the need for follow-
up, we allowed for an attrition rate of about 15%, resulting in a total baseline sample size of 
212 VLBW infants. The use of block-stratified randomization enhanced the study design 
sensitivity.
The diagnoses of preterm labor (PTL) and premature rupture of the membranes (PROM) 
were not discrete among the subjects. Consequently, we combined them into one variable 
PROM/PTL that represented women who had either diagnoses. Both conditions can be 
associated with intrauterine inflammation.17
Data analyses included Pearson Chi-Square tests, t-tests, Wilcoxon rank-sum tests for non-
normally distributed variables, and multiple logistic and linear regression models to adjust 
for possible confounders. No correction was used to adjust for multiple tests. For outcomes, 
odds ratios were calculated along with appropriate 95% confidence intervals. Primary 
analyses were conducted using intention-to-treat. Post-hoc sensitivity analyses using actual 
treatment were indicated and performed to assess the robustness of the findings.18
Results
Pregnant women (n=211) between 24 and 31.6 weeks gestation were randomized from May 
15, 2008, through August 31, 2014 (Figure 1; available at www.jpeds.com). There were 107 
infants in the ICC and 104 in the DCC group. Three infants were withdrawn (congenital 
anomalies and birth injury which precluded randomization), leaving a total sample of 208 
mother- infants dyads. Maternal and infant demographic and clinical variables were 
analyzed for the remaining randomized subjects. Neonatal morbidities were analyzed for the 
199 infants who survived the Neonatal Intensive Care Unit (NICU) course. There were 24 
(12%) protocol violations (9 ICC and 15 DCC group) that remained in their assigned groups 
for primary intention-to-treat analyses. One infant died after discharge, five refused follow-
up, and 32 were lost to follow-up. At 18–22 months, 82% (DCC) and 81% (ICC) were 
evaluated.
Table I shows the maternal and neonatal demographics and clinical characteristics. There 
were significantly more women with PROM/PTL in the DCC group in both cohorts, and 
more women with PEC at admission in the ICC group. There were no significant differences 
between the two groups in parity, public insurance, marital status, antenatal steroids, 
intrauterine growth restriction or cesarean delivery rate. Per protocol, cord clamping time 
was significantly increased in the infants in the DCC group. All other neonatal variables, 
including those used to assess protocol safety, did not differ between groups. There were no 
differences in numbers of infants who received phototherapy, days of phototherapy, delivery 
room resuscitation, or Score for Neonatal Acute Physiology (SNAP) scores at 12 hours of 
age (data not shown).
Table II shows that in initial analysis of the cohort there were no significant differences in 
the primary outcome variables of IVH and LOS at NICU discharge. Nine infants (3 = DCC 
and 6 = ICC) were removed from this analysis as they died before discharge. For each week 
of gestational age (GA) gained, the odds of IVH were reduced by 15% (OR .85, 95% CI .7 
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– .98) (data not shown). The diagnosis of PROM/PTL in the mother doubled the risk of IVH 
(OR 2, 95% CL 1, 4.3), and PEC lowered the risk by one-half (OR .5, 95% CL .2–1). When 
both PEC and PROM/PTL were included in a regression model, they balanced each other 
out leaving only GA to predict IVH.
Infants with LOS were younger at birth (mean of 26.7 versus 28.7 weeks, p <0.001); 22% (n 
= 15) of infants less than 28 weeks had LOS, and 9% (12) of those greater than 28 weeks 
had LOS (p = 0.008). Using regression analyses to predict LOS, we found no effect of PEC 
or PROM/PTL on LOS. Only GA predicted LOS with younger infants more affected as 
expected (OR .63, 95% CI .5 – .79) (data not shown).
There were no differences between the groups at seven-month corrected age assessments 
(data not shown). At 18–22 months, primary bivariate analysis by intention-to-treat showed 
no significant differences between groups on the Bayley-III motor assessment (Table II).
We completed sensitivity analyses because of the 12% rate of protocol violations and the 
symmetrically unequal groups on two major confounding variables. There were no 
differences between the two groups of infants with protocol violations on the 1- or 5-minute 
Apgar scores (data not shown). Using sensitivity analyses, no differences were found in the 
incidence of IVH or LOS (Table II). However, more than twice the number of children who 
received ICC scored less than 85 on the Bayley-III motor composite versus those who 
received DCC using the bivariate sensitivity analysis.
In Figure 2, multiple logistic regression analysis shows that if the child had DCC, the child’s 
chance of scoring less than 85 on the Bayley-III motor composite score was reduced by 68% 
after adjusting for known risk factors using intention-to-treat analysis and 76% using actual 
treatment (sensitivity analysis). If the mother had a history of clinical chorioamnionitis, her 
infant had 4-fold greater odds of scoring below 85. If the child had IVH, he had 6-fold 
increased odds of scoring less than 85 on the motor composite. Having public insurance 
more than doubled the child’s chances of scoring less than 85 on the motor composite. 
Scores under 70 points were predicted only by GA in all models (data not shown). The last 
bar represents the sensitivity analysis showing that the effect of DCC on Bayley-III motor 
scores less than 85 was stronger among the infants who actually received the intervention.
Eligible women delivering < 32 weeks (n = 121) not enrolled differed from the women 
randomized within the study on antenatal steroid use (ANS) (93% vs 98%, p = 0.009), rates 
of one ANS dose only (73% vs 27%, p <0.001), MgSO4 (13% vs 39%, p = <0.0001), hours 
of PROM (60% vs 76%, p = 0.002), chorioamnionitis (5% vs 15%, p = 0.0001), PROM 
(30% vs 39% p = 0.03), and births by cesarean (51% vs 66%, p = 0.005). Infants of these 
women differed from enrolled infants only on median temperatures on NICU admission 
(median 36.3 vs 36.5 degrees centigrade, p = 0.02). There were no differences in the 
incidence of IVH (18% vs 25%, p = 0.35).
Discussion
This study of VLBW preterm infants randomized to ICC versus DCC (plus milking) reports 
the motor outcomes at 18–22 months corrected age. Unbalanced groups with respect to two 
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powerful confounders, PEC and PROM/PTL, complicated the analyses. Nevertheless, the 
main finding from our study was that a brief delay in cord clamping was associated with 
better motor outcomes at 18–22 months when controlling for NICU morbidities and public 
health insurance as proxy for socioeconomic status.
The findings did not support our hypothesis that infants with DCC would have less IVH or 
LOS. Exploration of the data showed that conditions antecedent to birth had a powerful 
confounding effect on IVH. PEC, higher in the ICC group, reduced an infant’s odds of 
experiencing IVH by half. PROM/PTL, more prevalent among mothers randomized to the 
DCC group, doubled the infant’s odds of experiencing IVH. Recent research suggests 
probable mechanisms of action for the two opposite effects.19, 20
The mechanism for protection against IVH in infants born to women with PEC is not 
known. It is possible that intrauterine “stress” from maternal PEC protects the preterm infant 
against IVH by “maturing” the brain blood vessels especially those in the fragile germinal 
matrix (GM).20 Before 32 weeks gestation, high levels of vascular endothelial growth factor 
(VEGF) and angiopoietin stimulate the rapid growth in the vascular GM. Like 
indomethacin, PEC in the mother may suppress these important growth factors in the fetus 
allowing more time for the pericytes to cover and protect the vessels.20 Slowing the rapid 
growth may reduce the chance of rupture of these vessels into the GM when the infant is 
stressed by preterm birth.20
Conversely, PROM/PTL increased the infant’s chance of IVH after preterm birth twofold 
through inflammatory processes. There is robust evidence linking IVH with intrauterine 
inflammation.19, 21, 22 Inflammation with and without infection is known to cause release of 
pro-inflammatory cytokines into the amniotic fluid and surrounding tissues. These enter the 
fetus where they disrupt vascular tight junctions and cross the blood brain barrier. In the 
brain, this action continues especially in the rapidly growing vessels in the GM rendering 
them more fragile especially when the infant is stressed by preterm birth.23 Although the 
association between chorioamnionitis and PROM is well known, new evidence suggests that 
inflammation/infection may be a cause rather than a result of PROM and PTL.23 Bacteria 
release proteolytic enzymes that reduce the tensile strength and elasticity of the membranes. 
Even when the membranes remain intact, there is evidence that infection is associated with 
an increased production of cytokines known to inhibit progesterone synthesis, stimulate 
prostaglandin synthesis by the amnion and chorion, and thereby incite uterine contractility 
leading to preterm labor.21, 23, 24
We did not confirm our earlier findings of less LOS in infants who had DCC at birth.13 It is 
well known that smaller infants are more at risk for LOS.25 There was no evidence of 
confounding of the LOS results by PEC or PROM/PTL. Neither of the current meta-
analyses reported significant differences in the incidence of LOS.11, 12 In the Backes review 
which included only infants less than 32 weeks (n = 255), the odds ratio was 0.73 (CI 0.44, 
1.20) suggesting that the larger trials with younger infants (less than 30 weeks GA) and 
longer timing for delay underway in England26 and Australia may yield more definitive 
answers. (Tarnow-Mordi, personal communication).
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Manuck et al report that approximately one in four preterm infants (23–34 weeks) had 
neurodevelopmental impairment at two years of age.27 Possible mechanisms contributing to 
better motor outcomes at 18–22 months with DCC include increased overall blood volume 
(10 to 30%) offering the infant a more salutary neonatal transition and greater red cell mass 
for oxygenation and iron content.1, 2 Higher levels of red blood cells provide additional iron 
for the infant known to be neuroprotective at critical times in brain development as iron is 
essential for the proper maturation of the pre-oligodendrocytes.28, 29 Likewise, infants with 
DCC may have more hematopoietic stem cells (HSC) at birth. Infusions of HSCs soon after 
injury in animal models have both neuroprotective and neurorestorative effects.30–33 
Therefore, we suggest that additional iron and stem cells at birth may be the mechanisms 
that offer infants with DCC an advantage.
The differences between the subjects and the eligible women who did not enroll were 
probably due to the fact that the latter were more likely to deliver sooner after admission, 
allowing less time for the various procedures.
The sensitivity analyses demonstrates that the protocol violations in this study had only a 
small influence on the conclusions from the primary intention to treat analyses. Thabane et 
al suggest that sensitivity analyses are underused and recommend their use in every clinical 
trial.18
The major limitation of this study is the lack of a normal preterm control group. There may 
be confounders of which we remain unaware. There was some loss of equipoise in our 
institution but our sensitivity analyses showed that it had only a small impact on our results. 
It is not possible to assess the infants’ vital signs and breathing during such a short delay. 
Lastly, a delay of 30 to 45 seconds is very brief and would accordingly limit the magnitude 
of the placental transfusion. In spite of our conservative protocol, even this brief delay in 
cord clamping appears to benefit very preterm infants at 18–22 months corrected age. 
Current studies are underway that will provide transitional support and resuscitative 
measures with the cord intact for at least one to two minutes.26, 34 Further studies should 
provide some answers as to the value of longer placental support during neonatal transition.
Our protocol of a brief delay in cord clamping followed by one milking of the cord is safe. 
DCC may provide an advantage in reducing rates of poor motor performance at 18 to 22 
months corrected age. Although there were no group differences in rates of IVH and LOS in 
very preterm infants in this study, controlling for the major confounding factors of PEC and 
PROM/PTL revealed their significant and opposite impact on IVH. Further studies are 
needed to validate these findings.
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Figure 1. 
Flow chart of patients.
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Figure 2. 
Logistic Regression Analyses showing Risk Factors for Motor Composite Score <85. DCC, 
delayed cord clamping; ITT, intention-to-treat analysis; IVH, intraventricular hemorrhage; 
BPD, bronchopulmonary dysplasia; AT, actual treatment used for the sensitivity analysis.
Mercer et al. Page 11
J Pediatr. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Mercer et al. Page 12
Table 1
Maternal and Neonatal Demographics, Clinical, and Safety Variables
Characteristic
Initial Cohort 18 Month Cohort
DCC (n =103) ICC (n =105) DCC (n=82) ICC (n=79)
Mother’s age (yrs) 28 ± 7 29 ± 6.5 29 ± 7 30 ± 6
Race / Ethnicity
 Black 20 (20) 13 (12) 16 (20) 7 (9)
 White 56 (55) 69 (66) 44 (54) 56 (71)
 Other 26 (25) 23 (22) 21 (26) 16 (20)
Maternal Education- ≤ high school --- --- 37 (47) 24 (33)
PROM (hrs) 98 ± 190* 72 ± 190 112 ± 209* 80 ± 212
Reasons for preterm birth
 Preeclampsiaa 23 (22)* 39 (37) 19 (23) 29 (37)
 PROM/Preterm labora 77 (75)** 57 (54) 60 (73)** 42 (53)
 Clinical Chorioamnionitis 23 (22)** 10 (9.5) 18 (22)* 6 (8)
Gestational age, wks 28.3 ± 2 28.4 ± 2 28.1 ± 2 28.2 ± 2
24 to 276 wks 35 36 31 28
28 to 316 wks 68 69 51 51
Cord Clamp Time (seconds) Range, 
median
32 ± 16*** (0–60) 6.6 ± 6 (1–45) 31 ± 6*** (0–60) 6.6 ± 5.2 (0–36)
Birth weight, g 1203 ± 352 (430–
1955)
1136 ± 350 (390–
2455)
1178 ± 341 (480–
1885)
1101 ± 354 (390–
2455)
Male/female ratio 52/51 62/43 42/40 47/32
Apgar score, median (range)
1 min 6 (1–9) 6 (1–9) 6 (1–9) 6 (1–9)
5 min 8 (2–9) 8 (1–10) 8 (2–9) 8 (1–10)
<4 at 1 min, 16 (16) 20 (19) 13 (16) 14 (18)
Cord Blood Gas, Arterial 7.4 ± 0.1* 7.3 ± 0.1 7.3 ± 0.1 7.3 ± 0.1
NICU Admission Temperature CO 
(Range)
36.5 ± 0.8 (32–38) 36.3 ± 0.8 (33–39) 36.6 ± 0.8* (34–38) 36.3 ± 0.9 (33–38)
Initial Hematocrit (%) 47.6 ± 7 (31–63) 46.4 ± 7 (32–59) 47.2 ± 7 (31–63) 46.2 ± 7 (32–59)
1st Mean Blood Pressure 35 ± 8 35 ± 8 35± 8 34± 8
Peak bilirubin (mg/dl), First week, 
Range
8 ± 2 (5–16) 8 ± 2 (4–14) 8 ± 2 (5 –16) 7.7 ± 2 (4–14)
Mean ± SD or n (%);
*p<0.05;
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**p<0.01;
***p<0.001.
aOnly PEC and PROM/PTL are mutually exclusive categories.
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